Continuing immune checkpoint inhibitors beyond progression versus switching to non-ICI therapy in advanced gastric cancer: a real-world study - Quiz - MDSpire

Continuing immune checkpoint inhibitors beyond progression versus switching to non-ICI therapy in advanced gastric cancer: a real-world study

  • By

  • Guangxi Wang

  • Xiaonan Lu

  • Yunmei Wang

  • Xiang Wang

  • Ruoxuan Wang

  • Jinyu Jia

  • June 3, 2026

  • 0 min

Share

Original Source(s)

Continuing immune checkpoint inhibitors beyond progression versus switching to non-ICI therapy in advanced gastric cancer: a real-world study

  • by Guangxi Wang, Xiaonan Lu, Yunmei Wang, Xiang Wang, Ruoxuan Wang, Jinyu Jia

  • June 3, 2026

Related Content

Automated bone marrow cell classification using ensemble learning: performance, generalization, and clinical interpretability

Construction and validation of a nomogram model for predicting response to initial radioiodine therapy in differentiated thyroid cancer patients using serum cytokines combined with serum thyroglobulin

Predicting response to immunochemotherapy in EGFR-mutant lung adenocarcinoma after third-generation TKI resistance using CT radiomics-based habitat imaging